Profilo
Adrian G.
Howd is currently the Director at Viamet Pharmaceuticals, Inc., Independent Director at Viamet Pharmaceuticals Corp., Director & Principal at Brandon Point Industries Ltd., Director at Blueberry Therapeutics Ltd., and will be the Chief Financial & Business Officer at BiVictriX Therapeutics Plc starting in 2023.
Previously, he was the Chief Executive Officer at Malin Corp.
Plc from 2015 to 2018.
He also served as a Non-Executive Director at Kymab Ltd., Director at Poseida Therapeutics, Inc., Director at Wavebreak Therapeutics Ltd. from 2016 to 2018, Non-Executive Director at Immunocore Holdings Plc, and Executive Vice President at Evotec SE.
Dr. Howd started his career as a Research Analyst at ABN AMRO Bank NV (London Branch) in 2008 and later worked as a Research Analyst at Joh.
Berenberg, Gossler & Co. KG (United Kingdom) from 2009 to 2013.
He holds a doctorate degree from the University of London.
Posizioni attive di Adrian Howd
| Società | Posizione | Inizio |
|---|---|---|
| BIVICTRIX THERAPEUTICS PLC | Direttore Finanziario/CFO | 03/10/2023 |
Brandon Point Industries Ltd.
Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Operates as a life sciences company | Direttore/Membro del Consiglio | - |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Direttore/Membro del Consiglio | - |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Direttore/Membro del Consiglio | - |
Blueberry Therapeutics Ltd.
Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug research and development | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Adrian Howd
| Società | Posizione | Fine |
|---|---|---|
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Direttore/Membro del Consiglio | 28/10/2018 |
| MALIN CORPORATION PLC | Amministratore Delegato | 24/08/2015 |
Joh. Berenberg, Gossler & Co. KG (United Kingdom)
Joh. Berenberg, Gossler & Co. KG (United Kingdom) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/06/2013 |
ABN AMRO Bank NV (London Branch) (Broker) (Old)
ABN AMRO Bank NV (London Branch) (Broker) (Old) Regional BanksFinance Commercial foreign bank. | Analyst-Equity | 16/04/2008 |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Adrian Howd
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Health Technology |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Health Technology |
Malin Corp. Plc
Malin Corp. Plc BiotechnologyHealth Technology Provides life science services | Health Technology |
Evotec SE
Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
ABN AMRO Bank NV (London Branch) (Broker) (Old)
ABN AMRO Bank NV (London Branch) (Broker) (Old) Regional BanksFinance Commercial foreign bank. | Finance |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Joh. Berenberg, Gossler & Co. KG (United Kingdom)
Joh. Berenberg, Gossler & Co. KG (United Kingdom) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Brandon Point Industries Ltd.
Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Operates as a life sciences company | Health Services |
Blueberry Therapeutics Ltd.
Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug research and development | Health Technology |
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Health Technology |
BiVictriX Therapeutics Plc
BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics | Health Technology |
Immunocore Holdings Plc
Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
















